This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Last month, the patent battle between COVID-19 mRNA vaccine manufacturers continued with BioNTech/Pfizer filing a strong defense and counter-claim to Moderna’s allegations of patent infringement. Interestingly, as of January 12, 2023, Moderna has listed 10 patents covering Spikevax (its mRNA vaccine) on its website.
The COVID-19 pandemic has amplified this legal challenge and highlighted the need to treat liability as a key legal preparedness issue. The demand for liability protections reemerged in 2009 during H1N1, in attenuated form during the 2014-15 West Africa Ebola public health emergency, and, prominently, during COVID-19.
In addition to fielding scrutiny over mifepristone access , reviewing opioid regulations , and handling COVID-19vaccine and treatment approvals in the midst of a pandemic, Califf will be overseeing the FDA at a time when public health advocates are anticipating agency action on several tobacco issues.
The CARES Act was passed by Congress on March 27, 2020, to ensure that every American has access to the care they need during the COVID-19 pandemic and to address the economic fallout from the 2019 Novel Coronavirus and COVID-19. HIPAA Changes in 2020/2021 Due to the COVID-19 Pandemic Remain in Effect.
Colleagues question well-connected doctor’s UMC contract Report: 91% vaccinated for measles in Nevada Lombardo order addresses shortage of health care workers UNLV’s School of Medicine taking steps to fill physician shortage in Nevada Nevada approves using COVID relief funds for West Hills Facility rehabilitation $11.7
after cyberattack CHI St. lawmakers agree to make it easier to build new hospitals Hoar Begins Construction on $18.3M lawmakers agree to make it easier to build new hospitals Hoar Begins Construction on $18.3M migrants are a housing challenge. migrants are a housing challenge.
Those HIPAA updates were followed by the incorporation of the Health Information Technology for Economic and Clinical Health (HITECH) Act, which saw the introduction of the Breach Notification Rule in 2009 and the Omnibus Final Rule in 2013. HIPAA Changes Due to the 2019 Novel Coronavirus (SARS-CoV-2) and COVID-19.
US flu hospitalization rate highest its been since 2009 swine flu pandemic, experts say. A ‘tripledemic’ of flu, RSV and COVID is feared in California. Waterbury Woman Who Created False COVID-19Vaccine Records is Sentenced. Will Illinois Schools Require COVIDVaccines for Students? CONNECTICUT.
15, 2024) (“ CHD ”), the Third Circuit affirmed the right of a publicly supported university to require COVID-19vaccination as a prerequisite to its students’ in-person attendance. First of all, only one of the plaintiffs ever sought vaccination, so the rest were never entitled to informed consent at any time.
We organize all of the trending information in your field so you don't have to. Join 26,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content